HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Scerene Healthcare Plans 2010 Entry With Puristics Lines

This article was originally published in The Rose Sheet

Executive Summary

Scerene Healthcare, a consumer health-care company founded by OTC industry veterans, will launch in spring 2010 with three product lines under the Puristics nameplate - anti-aging skin care, baby care and feminine hygiene

You may also be interested in...



Scerene Aims “Pure And Effective” Puristics Brand At Mass Market

Peapack, N.J.-based Scerene Healthcare Inc. looks to take on established skin-care players Procter & Gamble and L’Oreal with Puristics, a brand the firm is pricing to compete at mass retailers and positioning as both “pure and effective.”

OCA Applauds Organic Board's Recommendation To USDA: "Outlaw Nanotech"

With a push from the Organic Consumers Association, the National Organic Standards Board is recommending that the use of nanotechnology be strictly prohibited from products certified under the National Organic Program

Latest Headlines
See All
UsernamePublicRestriction

Register

RS016553

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel